Veterinary Medicines

REPIDOSE FARMINTIC 5-750 DISPOSITIF INTRARUMINAL A LIBERATION SEQUENTIELLE

Authorised
  • Oxfendazole
Download as PDF

Product identification

Medicine name:
REPIDOSE FARMINTIC 5-750 DISPOSITIF INTRARUMINAL A LIBERATION SEQUENTIELLE
Active substance:
  • Oxfendazole
Target species:
  • Cattle
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Oxfendazole
    750.00
    milligram(s)
    /
    1.00
    System
Pharmaceutical form:
  • Pulsatile-release intraruminal device
Withdrawal period by route of administration:
  • Oral use
    • Cattle
      • Meat and offal
        180
        day
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Intervet
Marketing authorisation date:
Manufacturing sites for batch release:
  • MSD Animal Health UK Limited
  • Intervet Ges.m.b.H.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/9648488 9/1993
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 10/01/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025
Download